Etoricoxib contains not less than 98.0% and not more than 102% of C18H15ClN2O2S, calculated on anhydrous basis.

依托考昔
Etoricoxib

• 申請商: 宇直泰貿易股份有限公司
• 適應症: 消炎止痛
• 含量: 0